Skip to content

BioLife Solutions, Inc.: 10-Q filed 2017-08-11

What BioLife Solutions, Inc. reported in its quarterly report filed 2017-08-11 (fiscal Q2 2017): 32 published measures, 84 facts as tagged in accession 0001144204-17-042202.

This filing

Form
10-Q (quarterly report)
Filed
2017-08-11
Fiscal period
fiscal Q2 2017
Accession
0001144204-17-042202 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioLife Solutions, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-06-308,481,722USD
At 2016-12-317,926,614USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-06-301,660,764USD
At 2016-12-314,760,474USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-06-302,314,633USD
At 2016-12-311,405,826USD
At 2016-06-301,318,469USD
At 2015-12-312,173,258USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-04-01 to 2017-06-30-768,212USD91
2017-01-01 to 2017-06-30-1,638,502USD181
2016-04-01 to 2016-06-30-1,356,083USD91
2016-01-01 to 2016-06-30-2,582,911USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-01-01 to 2017-06-3078,185USD181
2016-01-01 to 2016-06-3099,353USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-06-30-72,868,779USD
At 2016-12-31-71,202,369USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-06-301,180,882USD
At 2016-12-311,187,378USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-01-01 to 2017-06-30643,768USD181
2016-01-01 to 2016-06-30402,763USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-04-01 to 2017-06-30-341,203USD91
2017-01-01 to 2017-06-30-805,242USD181
2016-04-01 to 2016-06-30-1,593,889USD91
2016-01-01 to 2016-06-30-3,086,321USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-06-305,679,147USD
At 2016-12-314,628,070USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-06-301,045,091USD
At 2016-12-311,133,163USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-06-30531,919USD
At 2016-12-31710,719USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-06-301,173,036USD
At 2016-12-311,193,646USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-04-01 to 2017-06-301,942,129USD91
2017-01-01 to 2017-06-303,843,967USD181
2016-04-01 to 2016-06-302,711,042USD91
2016-01-01 to 2016-06-305,284,486USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-06-301,769,070USD
At 2016-12-311,757,784USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-04-01 to 2017-06-301,600,926USD91
2017-01-01 to 2017-06-303,038,725USD181
2016-04-01 to 2016-06-301,117,153USD91
2016-01-01 to 2016-06-302,198,165USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-04-01 to 2017-06-30318,607USD91
2017-01-01 to 2017-06-30605,358USD181
2016-04-01 to 2016-06-30599,031USD91
2016-01-01 to 2016-06-301,103,270USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-06-3013,210,015shares
At 2016-12-3112,863,824shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2017-06-306,820,958USD
At 2016-12-313,166,140USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-06-303,027,378USD
At 2016-12-312,857,623USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-06-301,846,496USD
At 2016-12-311,670,245USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2017-06-3056,141USD
At 2016-12-310USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-06-3063,619USD
At 2016-12-31116,399USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-06-30422,408USD
At 2016-12-31270,814USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2017-04-01 to 2017-06-30-768,212USD91
2017-01-01 to 2017-06-30-1,638,502USD181
2016-04-01 to 2016-06-30-1,719,712USD91
2016-01-01 to 2016-06-30-3,210,225USD182

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-04-01 to 2017-06-30-768,212USD91
2017-01-01 to 2017-06-30-1,638,502USD181
2016-04-01 to 2016-06-30-1,356,083USD91
2016-01-01 to 2016-06-30-2,582,460USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-04-01 to 2017-06-301,077,067USD91
2017-01-01 to 2017-06-302,180,210USD181
2016-04-01 to 2016-06-301,262,818USD91
2016-01-01 to 2016-06-302,598,110USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-01-01 to 2017-06-30176,251USD181
2016-01-01 to 2016-06-30183,893USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-04-01 to 2017-06-30-427,009USD91
2017-01-01 to 2017-06-30-833,260USD181
2016-04-01 to 2016-06-30-125,823USD91
2016-01-01 to 2016-06-30-123,904USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-06-30-20,610USD181
2016-01-01 to 2016-06-30354,726USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-06-3011,286USD181
2016-01-01 to 2016-06-3076,094USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-06-30-124,239USD181
2016-01-01 to 2016-06-30207,369USD182

Inspect the source

Entity
BioLife Solutions, Inc. / CIK 0000834365
Captured
2026-09-19T15:08:45.571Z
SEC response SHA-256
cc2cf8f92622e29fea17afa7805fcf370f2d2caa2d36b6cf780e7beb9e287e2f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000834365.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))